Multiple myeloma: five-year experience at a University Hospital

Area of Science:

• Hematology
• Oncology

Background:

• Multiple myeloma is a hematologic malignancy.
• Understanding patient demographics and survival is crucial for treatment strategies.

Purpose of the Study:

• To conduct a descriptive analysis of multiple myeloma patients.
• To correlate patient characteristics with mortality outcomes.

Main Methods:

• Retrospective analysis of consecutive multiple myeloma patients.
• Data collected from Faculdade de Medicina do ABC between 2006 and 2010.

Main Results:

• Median patient age was 58.5 years.
• High prevalence of anemia (87%) and M protein (85.7%) at diagnosis.
• Five-year survival rate was 74.6%, with Durie-Salmon staging significantly correlating with survival (p = 0.037).

Conclusions:

• Multiple myeloma cases in this tertiary public healthcare service represent a younger population with advanced staging.
• Survival outcomes are comparable to existing literature findings.
• Further research into early detection and treatment is warranted.